Global Vascular Endothelial Growth Factor B Market By Product Type (Aflibercept, Aflibercept Biosimilar) And By End-Users/Application (Rectal Cancer, Retinal Vein Occlusion) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985533
  • April 2021
  • Pharmaceuticals
  • 119 Pages

Report Preview

The Vascular Endothelial Growth Factor B Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Vascular Endothelial Growth Factor B Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Vascular Endothelial Growth Factor B Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Vascular Endothelial Growth Factor B market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Aflibercept, Aflibercept Biosimilar, CSL-346, Others
Applications Rectal Cancer, Retinal Vein Occlusion, Diabetic Nephropathy, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Alteogen Inc, CSL Ltd, Eli Lilly and Company, Formycon AG, Regeneron Pharmaceuticals Inc
 
Vascular Endothelial Growth Factor B Market Competitive and Premeditated Analysis
In the Vascular Endothelial Growth Factor B report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Vascular Endothelial Growth Factor B research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Vascular Endothelial Growth Factor B Market Segmentation Analysis:
The Vascular Endothelial Growth Factor B market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes Aflibercept, Aflibercept Biosimilar, CSL-346, Others   

The application segment includes   Rectal Cancer, Retinal Vein Occlusion, Diabetic Nephropathy, Others

Major Key Players for Global Vascular Endothelial Growth Factor B Market:
The Vascular Endothelial Growth Factor B market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alteogen Inc, CSL Ltd, Eli Lilly and Company, Formycon AG, Regeneron Pharmaceuticals Inc
 
The Vascular Endothelial Growth Factor B market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Vascular Endothelial Growth Factor B market:
The Vascular Endothelial Growth Factor B market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Vascular Endothelial Growth Factor B market:
By Type:
  • Aflibercept
  • Aflibercept Biosimilar
  • CSL-346
  • Others

By Application
  • Rectal Cancer
  • Retinal Vein Occlusion
  • Diabetic Nephropathy
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Vascular Endothelial Growth Factor B report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Vascular Endothelial Growth Factor B market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Vascular Endothelial Growth Factor B market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Vascular Endothelial Growth Factor B market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Vascular Endothelial Growth Factor B market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Vascular Endothelial Growth Factor B market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Vascular Endothelial Growth Factor B market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Vascular Endothelial Growth Factor B market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Vascular Endothelial Growth Factor B market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Vascular Endothelial Growth Factor B Market Snapshot
          2.1.1. Global Vascular Endothelial Growth Factor B Market By Type,2019
               2.1.1.1.Aflibercept
               2.1.1.2.Aflibercept Biosimilar
               2.1.1.3.CSL-346
               2.1.1.4.Others
          2.1.2. Global Vascular Endothelial Growth Factor B Market By Application,2019
               2.1.2.1.Rectal Cancer
               2.1.2.2.Retinal Vein Occlusion
               2.1.2.3.Diabetic Nephropathy
               2.1.2.4.Others
          2.1.3. Global Vascular Endothelial Growth Factor B Market By End-use,2019
          2.1.4. Global Vascular Endothelial Growth Factor B Market By Geography,2019

3. Global Vascular Endothelial Growth Factor B Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028

5. Global Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028

6. Global Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028

7. Global Vascular Endothelial Growth Factor B Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Vascular Endothelial Growth Factor B Market Analysis, 2018 – 2028 
          7.2.1. North America Vascular Endothelial Growth Factor B Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Vascular Endothelial Growth Factor B Market Analysis, 2018 – 2028 
          7.3.1.  Europe Vascular Endothelial Growth Factor B Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Vascular Endothelial Growth Factor B Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Vascular Endothelial Growth Factor B Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Vascular Endothelial Growth Factor B Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Vascular Endothelial Growth Factor B Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Vascular Endothelial Growth Factor B Market Analysis, 2018 – 2028 
          7.6.1.  MEA Vascular Endothelial Growth Factor B Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Vascular Endothelial Growth Factor B Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Vascular Endothelial Growth Factor B Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Vascular Endothelial Growth Factor B Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Vascular Endothelial Growth Factor B Providers
        8.4.1 Alteogen Inc
                8.1.1 Business Description
                8.1.2 Alteogen Inc Geographic Operations
                8.1.3 Alteogen Inc Financial Information
                8.1.4 Alteogen Inc Product Positions/Portfolio
                8.1.5 Alteogen Inc Key Developments
        8.4.2 CSL Ltd
                8.2.1 Business Description
                8.2.2 CSL Ltd Geographic Operations
                8.2.3 CSL Ltd Financial Information
                8.2.4 CSL Ltd Product Positions/Portfolio
                8.2.5 CSL Ltd Key Developments
        8.4.3 Eli Lilly and Company
                8.3.1 Business Description
                8.3.2 Eli Lilly and Company Geographic Operations
                8.3.3 Eli Lilly and Company Financial Information
                8.3.4 Eli Lilly and Company Product Positions/Portfolio
                8.3.5 Eli Lilly and Company Key Developments
        8.4.4 Formycon AG
                8.4.1 Business Description
                8.4.2 Formycon AG Geographic Operations
                8.4.3 Formycon AG Financial Information
                8.4.4 Formycon AG Product Positions/Portfolio
                8.4.5 Formycon AG Key Developments
        8.4.5 Regeneron Pharmaceuticals Inc
                8.5.1 Business Description
                8.5.2 Regeneron Pharmaceuticals Inc Geographic Operations
                8.5.3 Regeneron Pharmaceuticals Inc Financial Information
                8.5.4 Regeneron Pharmaceuticals Inc Product Positions/Portfolio
                8.5.5 Regeneron Pharmaceuticals Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Vascular Endothelial Growth Factor B Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Vascular Endothelial Growth Factor B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Vascular Endothelial Growth Factor B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Vascular Endothelial Growth Factor B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Vascular Endothelial Growth Factor B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Vascular Endothelial Growth Factor B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Vascular Endothelial Growth Factor B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Vascular Endothelial Growth Factor B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Vascular Endothelial Growth Factor B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Vascular Endothelial Growth Factor B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Vascular Endothelial Growth Factor B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Vascular Endothelial Growth Factor B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Vascular Endothelial Growth Factor B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Vascular Endothelial Growth Factor B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Vascular Endothelial Growth Factor B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Vascular Endothelial Growth Factor B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Vascular Endothelial Growth Factor B: Market Segmentation 
FIG. 2 Global Vascular Endothelial Growth Factor B Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Vascular Endothelial Growth Factor B Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Vascular Endothelial Growth Factor B Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Vascular Endothelial Growth Factor B Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Vascular Endothelial Growth Factor B Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Vascular Endothelial Growth Factor B Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Vascular Endothelial Growth Factor B Providers, 2019
FIG. 11 Global Vascular Endothelial Growth Factor B Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Vascular Endothelial Growth Factor B Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Vascular Endothelial Growth Factor B Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Vascular Endothelial Growth Factor B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Vascular Endothelial Growth Factor B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Vascular Endothelial Growth Factor B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Vascular Endothelial Growth Factor B Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Vascular Endothelial Growth Factor B Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Vascular Endothelial Growth Factor B market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Vascular Endothelial Growth Factor B Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Vascular Endothelial Growth Factor B Market Value, By Segment1, 2018 – 2028
TABLE  North America Vascular Endothelial Growth Factor B Market Value, By Segment2, 2018 – 2028
TABLE  North America Vascular Endothelial Growth Factor B Market Value, By Country, 2018 – 2028
TABLE  Europe Vascular Endothelial Growth Factor B Market Value, By Segment1, 2018 – 2028
TABLE  Europe Vascular Endothelial Growth Factor B Market Value, By Segment2, 2018 – 2028
TABLE  Europe Vascular Endothelial Growth Factor B Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Vascular Endothelial Growth Factor B Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Vascular Endothelial Growth Factor B Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Vascular Endothelial Growth Factor B Market Value, By Country, 2018 – 2028
TABLE  Latin America Vascular Endothelial Growth Factor B Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Vascular Endothelial Growth Factor B Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Vascular Endothelial Growth Factor B Market Value, By Country, 2018 – 2028
TABLE  MEA Vascular Endothelial Growth Factor B Market Value, By Segment1, 2018 – 2028
TABLE  MEA Vascular Endothelial Growth Factor B Market Value, By Segment2, 2018 – 2028
TABLE  MEA Vascular Endothelial Growth Factor B Market Value, By Country, 2018 – 2028
TABLE  Alteogen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CSL Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Formycon AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Regeneron Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Vascular Endothelial Growth Factor B Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Vascular Endothelial Growth Factor B Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Vascular Endothelial Growth Factor B Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Vascular Endothelial Growth Factor B Market, By Geography, 2019 (US$ Mn)
FIG.  Global Vascular Endothelial Growth Factor B Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Vascular Endothelial Growth Factor B Providers, 2016
FIG.  Global Vascular Endothelial Growth Factor B Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Aflibercept Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Aflibercept Biosimilar Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CSL-346 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vascular Endothelial Growth Factor B Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Rectal Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Retinal Vein Occlusion Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetic Nephropathy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Vascular Endothelial Growth Factor B Market Value, 2018 – 2028, (US$ Mn)